Medtronic PLC
MDT Healthcare Medical Devices
Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025. In the quarter to July 2026, revenue grew 13.7%, EPS grew 42.0%, free cash flow grew 120.9% and total debt fell 1.59%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three.
Follow MDT
Medtronic PLC (MDT) Revenue
Medtronic PLC's revenue for fiscal 2026 was $36.4B, up 8.43% from $33.5B in fiscal 2025. Over the twelve months to 31 July 2026 it was $37.5B. Over the past ten years it has ranged from $20.3B (fiscal 2015) to $36.4B (fiscal 2026) — the current reading is the highest in ten years. Revenue has risen for 3 consecutive fiscal years. Medtronic PLC ranks 2nd of 140 Medical Devices companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2026 | $36.4B | 8.43% |
| FY2025 | $33.5B | 3.62% |
| FY2024 | $32.4B | 3.64% |
| FY2023 | $31.2B | (1.45%) |
| FY2022 | $31.7B | 5.21% |
| FY2021 | $30.1B | 4.16% |
| FY2020 | $28.9B | (5.38%) |
| FY2019 | $30.6B | 2.02% |
| FY2018 | $30.0B | 0.82% |
| FY2017 | $29.7B | 3.04% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Jul 2026 | $9.8B | (0.53%) |
| Apr 2026 | $9.8B | 8.77% |
| Jan 2026 | $9.0B | 0.62% |
| Oct 2025 | $9.0B | 4.46% |
| 43 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| ABT Abbott Laboratories compare | $46.6B |
| MDT Medtronic PLC | $37.5B |
| SYK Stryker Corporation compare | $25.8B |
| GEHC GE HealthCare Technologies Inc. compare | $21.3B |
| BSX Boston Scientific Corporation compare | $21.0B |
| PHG Koninklijke Philips N.V. compare | $20.6B |
| EW Edwards Lifesciences Corporation compare | $6.5B |
| STE STERIS plc compare | $6.0B |
| DXCM DexCom, Inc. compare | $5.0B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on MDT
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement